[Federal Register Volume 62, Number 50 (Friday, March 14, 1997)]
[Notices]
[Page 12250]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-6514]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Agency Information Collection Activities: New Collection; Comment
Request
ACTION: Notice of information collection under review; Collection of
laboratory analysis data on drug samples tested by non-Federal (state
and local government) crime laboratories.
-----------------------------------------------------------------------
The proposed information collection is published to obtain comments
from the public and affected agencies. Comments are encouraged and will
be accepted until May 13, 1997.
We are requesting written comments and suggestions from the public
and affected agencies concerning the proposed collection of
information. Your comments should address one or more of the following
four points:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Comments and/or suggestions regarding the item(s) contained in this
notice, especially regarding the estimated public burden and associated
response time should be directed to Mr. Frank L. Sapienza, Chief, Drug
and Chemical Evaluation Section, Office of Diversion Control, Drug
Enforcement Administration, Washington, D.C. 20537. Telephone: (202)
307-7183; or Fax: (202) 307-8570. If you have additional comments,
suggestions, or need a copy of the proposed information collection
instrument with instructions, or additional information, please contact
Mr. Frank L. Sapienza.
Additionally, comments may also be submitted to the Department of
Justice (DOJ), Justice Management Division, Information Management and
Security Staff, Attention: Department Clearance Officer, Suite 850,
Washington Center, 1001 G Street, NW, Washington, DC 20530. Additional
comments may be submitted to DOJ via facsimile at 202-514-1590.
Overview of this information collection:
1. Type of Information Collection: New Collection.
2. Title of the Form/Collection: Collection of analyzed drug data
from non-Federal forensic crime laboratories.
3. Agency form number: None; Applicable component of the Department
of Justice sponsoring the collection: Office of Diversion Control, Drug
Enforcement Administration, Department of Justice.
4. Affected public who will be asked to respond, as well as a brief
abstract: Primary: State and local crime laboratories. Other: None.
DEA is required under the Controlled Substances Act (CSA) [21
U.S.C. 811 (b)] to gather data relevant to a determination of the
actual or relative abuse potential of drugs. Existing Federal drug
abuse data bases do not provide the type or quality of information
necessary to accomplish this task in a timely and efficient manner.
Non-Federal crime laboratories conduct chemical analyses on a
significantly larger number of illicit drug samples than DEA's seven
laboratories. The non-Federal analyzed drug data is an untapped
resource which would give DEA a very comprehensive representation of
drug trafficking in the U.S. This data has the highest degree of
validity because it is verified by chemical analysis. DEA is
coordination this voluntary, cooperative program to provide a
centralized source of analyzed laboratory drug data. Participating
laboratories and other government agencies will be permitted to access
part of the data base.
5. An estimate of the total number of respondents and the amount of
time estimated for an average respondent to respond: 330 respondents at
12 times per year at 8 hours per response.
6. An estimate of the total public burden (in hours) associated
with the collection: 31,680 annual burden hours.
Public comment on this proposed information collection is strongly
encouraged.
Dated: March 11, 1997.
Robert B. Briggs,
Department Clearance Officer, United States Department of Justice.
[FR Doc. 97-6514 Filed 3-13-97; 8:45 am]
BILLING CODE 4410-09-M
